The Computational Science of Drug Development
Listen now
Description
At the beginning of 2020, while a pandemic of epic proportions shut down most of the world, the life sciences industry was kicked into high gear, pushing to do what had never been done before – create a vaccine in less than four years.  Thankfully, modern day computational science lended a hand, making the previously impossible, possible.  In this episode, we speak to someone on the front lines of vaccine and drug development – Steve Mehrman of Johnson & Johnson, who harnesses computational power on a daily basis to elevate one of the most important aspects of our lives – human health.
More Episodes
We’ve all been there – Sitting inside a movie theater, fully engrossed in the film, when suddenly something happens on screen that is so far-fetched that we suddenly remember we’re sitting in a theater seat. This is the experience Rescale’s Edward Hsu had back in 2012 when he was watching the...
Published 09/26/23
Published 09/26/23
With high performance cloud computing usage expanding quickly in research & development, there are still some organizations who hesitate to dip a toe. In this episode, Ernest and Jolie talk through common fears of moving workloads from on premises to the cloud, and what those fears mean in...
Published 07/06/23